from Aim for the Cure
7 months, 1 week ago from Aim for the Cure
Family friendly walk will raise funds to support research for the CURE of melanoma
AIM at Melanoma, a nonprofit organization and leader at the forefront of research, education, legislation, and awareness will see hundreds of walkers on April 5, 2014 at its 5th annual charity walk at South Park located at 12th and Harrison streets in Quincy. All proceeds from the walk will benefit ongoing research to find the CURE for melanoma – a deadly form of skin cancer.
In 2009, Quincy launched its first AIM for the CURE Melanoma Walk in honor of Jim Schlipmann, the brother of walk coordinator Jean Anne Cook, who lost his battle with melanoma at only 44 years young. Melanoma is the deadliest type of skin cancer in the U.S. according to the CDC. The National Cancer Institute estimates in 2014 there will be 76,100 new cases and 9,710 deaths. One of the fastest growing cancers in the U.S., the American Cancer Society states that melanoma is the most common cancer in adolescents and young adults and the numbers are soaring. In its advanced forms – even with treatment and surgery – the survival rate five years after diagnosis is less than 5 percent.
AIM funds melanoma research, provides education and comprehensive and accessible resources for patients, survivors and caregivers. AIM championed landmark legislation prohibiting minors from using indoor tanning salons and ushered in legislation requiring insurers to provide coverage for oral medication that is equivalent to conventional intravenous drugs used in chemotherapy.
Walk registration sign-in begins at 8:00 a.m. and activities will kick off with free Derma Scans provided by Community Outreach Educator, Stephanie Wiley. Also on site providing free skin cancer screenings will be Karilyn Crook, PA-C from Quincy Medical Group. The opening ceremony will begin at 9:00 am and this year’s walk will be emceed by Steve Felde, Sr. Communications Specialist from Blessing Hospital. Registration is free however participants are encouraged to raise at least $50. “We encourage participants to walk in honor of a melanoma patient or survivor, in loving memory of someone special who lost their battle with this disease or just to show their support and create awareness,” said AIM Co-Founder Jean Schlipmann.
AIM at Melanoma, founded in memory of Charlie Guild, who died of melanoma at the age of 26 and Jim Schlipmann, who died from the disease at 44, is the largest international melanoma foundation focused on melanoma research, education, legislation, and awareness. The foundation supports melanoma research efforts by hosting international research forums and is helping to create the first international melanoma tissue bank, widely believed by the oncology community to be a key to major breakthroughs in melanoma research. To learn more about AIM, visit www.AIMatMelanoma.org.